Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q1 2025 (March 31)5holders −1
0new positions
1sold out
$0.99avg. 13F price*
At the end of Q1 2025, 5 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Sonora Investment Management Group, LLC ($5.3M), New York State Common Retirement Fund ($4.8M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.4M).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $36K |
All 13F filers, Q4 2024 → Q1 2025: 510,302 shares sold, net −510,302 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Sonora Investment Management Group, LLC | 0.43% | No change | 5,499,000 | $5.3M |
| New York State Common Retirement Fund | 0.01% | Reduce -7.6% | 4,956,000 | $4.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Reduce 0.0% | 2,499,999 | $2.4M |
| Nomura Holdings Inc. | 0.00% | Reduce -86.0% | 10,981 | $331K |
| Sei Investments Co. | 0.00% | No change | 262,000 | $254K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.